Intervacc AB (OSTO:IVACC) Short-Term Debt : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB Short-Term Debt?

Intervacc AB's Short-Term Debt for the quarter that ended in Mar. 2024 was kr0.00 Mil.

Intervacc AB's quarterly Short-Term Debt increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr0.04 Mil) but then declined from Dec. 2023 (kr0.04 Mil) to Mar. 2024 (kr0.00 Mil).

Intervacc AB's annual Short-Term Debt declined from Dec. 2021 (kr0.21 Mil) to Dec. 2022 (kr0.14 Mil) and declined from Dec. 2022 (kr0.14 Mil) to Dec. 2023 (kr0.04 Mil).

Intervacc AB Short-Term Debt Historical Data

The historical data trend for Intervacc AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intervacc AB Short-Term Debt Chart

Intervacc AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

0.34

0.21

0.14

0.04

Intervacc AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	0.04	-

Intervacc AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Intervacc AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Intervacc AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Intervacc AB (OSTO:IVACC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

2E9:Germany

Address

Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44

Website

https://www.intervacc.se

Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Intervacc AB (OSTO:IVACC) Headlines

No Headlines